|
RiboMed Biotechnologies, Inc., a CLIA-certified diagnostic company, today announced the receipt of a $165,000 Small Business Innovative Research contract awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The project, entitled “Non-invasive assay for the diagnosis and treatment of endometriosis” will focus on the development of a test for early detection of endometriosis from a woman’s bodily fluids using an epigenetic biomarker panel, including gene-specific DNA methylation.
Breezing, a spinout company that was the result of discoveries made at Arizona State University’s Biodesign Institute, was recently named an Arizona Innovation Challenge winner by the Arizona Commerce Authority.
University of Arizona, Cox Communications Team Up for Fifth Annual Family-Friendly Event to Inspire All Ages
Midwestern University President and Chief Executive Officer Kathleen H. Goeppinger, Ph.D., was recently appointed as a commissioner for the Western Interstate Commission for Higher Education (WICHE), a Federal interstate compact of 16 Western states and territories that work collaboratively to expand educational access and excellence for all citizens of the West.
Thirty four companies given the opportunity to present for a chance to earn cash prizes, access to investors, recognition and the coveted title of Venture Madness Champion
Pinnacle Transplant Technologies, a regenerative medical company with a focus on providing safe, quality driven products to improve lives through innovation, collaboration, and teamwork, announced the addition of Roger Rose as Chief Executive Officer on January 8, 2019.
Award Allows the VA, Indian Health Services and Other Federal Agencies to Order and Prescribe Axolotl Biologix Products
EV-D68 is confirmed among AFM patients at Phoenix-area hospital
On Tuesday, January 22, 2019, the U.S. Supreme Court held in a unanimous decision that, even where the details of the invention are kept confidential, a commercial sale may place the invention “on sale” under the Leahy-Smith America Invents Act (“AIA”). Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.
Xcellerate Biomedical Technologies, a new company based in Phoenix, AZ, has unveiled a brand of professional botanical-based products – BioXskincare — including a scar cream, stretch mark cream and antiaging product that accelerate healing and collagen growth.
|
